T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates.

Abstract excerpt

T cell receptor (TCR) β V and J usage correlates with either the HLA class I or HLA class II major histocompatibility subtypes, and in both infectious diseases and autoimmune settings, the use of particular TCR-β V and J's, in persons with specific HLA alleles, represents either better outcomes or certain clinical features. However, the relationship of TCR V and J usage, HLA alleles, and clinical parameters in...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Disease-Free Survival
• Share to Genes, MHC Class I
• Share to Genes, MHC Class II